SCHEMBL24919815

SCHEMBL24919815

c1ccc(-c2ccccc2N(c2cccc(-c3ccc4ccccc4c3)c2)c2ccc3c(c2)oc2ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.37
▸ HSD17B1 P14061 2/20 0.34
▸ HSD17B2 P37059 2/20 0.34
▸ AHR P35869 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CYP1A1 P04798 2/20 0.33
▸ CYP1B1 Q16678 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CASP3 P42574 1/20 0.32
▸ SENP7 Q9BQF6 1/20 0.32
▸ SENP6 Q9GZR1 1/20 0.32
▸ ANO1 Q5XXA6 1/20 0.32
▸ MMP12 P39900 1/20 0.32
▸ MMP13 P45452 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27274205 1.00 HCRTR1 (0.37) HCRTR1HSD17B1HSD17B2AHRALDH1A1
SCHEMBL23225291 0.99 HCRTR1 (0.36) HCRTR1HSD17B1HSD17B2AHRALDH1A1
SCHEMBL27274207 0.99 HCRTR1 (0.36) HCRTR1HSD17B1HSD17B2AHRALDH1A1
SCHEMBL24472577 0.97 HCRTR1 (0.35) HCRTR1HSD17B1HSD17B2AHRALDH1A1
SCHEMBL24471713 0.97 HCRTR1 (0.35) HCRTR1HSD17B1HSD17B2AHRALDH1A1
SCHEMBL24471999 0.96 HCRTR1 (0.34) HCRTR1HSD17B1HSD17B2AHRALDH1A1
SCHEMBL23225046 0.96 HCRTR1 (0.38) HCRTR1HSD17B1HSD17B2AHRALDH1A1
SCHEMBL24919362 0.96 HCRTR1 (0.38) HCRTR1HSD17B1HSD17B2AHRALDH1A1
SCHEMBL24964681 0.96 HCRTR1 (0.39) HCRTR1HSD17B1HSD17B2AHRALDH1A1
SCHEMBL27273441 0.96 HCRTR1 (0.34) HCRTR1HSD17B1HSD17B2AHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 HCRTR1 4011/4885HSD17B1 2196/4885HSD17B2 2389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback